Your browser doesn't support javascript.
loading
Assessment of the effect of the Aquamantys® system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching.
Sui, M H; Wang, H G; Chen, M Y; Wan, T; Hu, B Y; Pan, Y W; Li, H; Cai, H Y; Cui, C; Lu, S C.
Afiliação
  • Sui MH; Medical School of Chinese PLA, 28 Fuxing Road, Beijing, 100853, China.
  • Wang HG; Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, 100853, China.
  • Chen MY; Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, 100853, China.
  • Wan T; Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, 100853, China.
  • Hu BY; Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, 100853, China.
  • Pan YW; Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, 100853, China.
  • Li H; Medical School of Chinese PLA, 28 Fuxing Road, Beijing, 100853, China.
  • Cai HY; NanKai University, Tianjin, 300071, China.
  • Cui C; Medical School of Chinese PLA, 28 Fuxing Road, Beijing, 100853, China.
  • Lu SC; Medical School of Chinese PLA, 28 Fuxing Road, Beijing, 100853, China. lsc_med@126.com.
Clin Transl Oncol ; 21(12): 1634-1643, 2019 Dec.
Article em En | MEDLINE | ID: mdl-30911882
OBJECTIVE: To assess the effect of the intraoperative application of the Aquamantys® system to treat the hepatic resection margin on local and overall recurrence of HCC. METHODS: We retrospectively analyzed 101 patients admitted from November 2016 to June 2018 who underwent hepatectomy using the Aquamantys® as hemostatic device, who were matched with 101 patients (control group) using conventional hemostatic devices through PSM. Univariate and multivariate analyses of recurrence-free survival (RFS) and local recurrence-free survival (LRFS) were performed using the Cox proportional hazard model. RESULTS: There were no significant differences in baseline data and surgical procedures between the two groups. The Aquamantys® group showed less blood loss (P = 0.005) and a lower blood transfusion rate (P = 0.036), while the incidences of postoperative complications of the two groups showed no difference (P = 0.266). OS rates of the Aquamantys® group and the control group were 82.6% and 84.2%, respectively (P = 0. 446), and RFS rates were 65.5% and 58.2%, respectively (P = 0.153), with no significant differences. The Aquamantys® group and the control group had two cases and 11 cases of local recurrence, respectively, with LRFS rates of 98% and 87.9%, respectively, in the follow-up period, corresponding to a significant difference (P = 0.011). Multivariate analysis showed that microvascular invasion (MVI), tumor diameter > 5 cm, and the control group were independent risk factors for LRFS. CONCLUSION: Our results indicate that application of the Aquamantys® system in hepatectomy can reduce local recurrence, but it can neither reduce overall recurrence nor improve OS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Eletrocirurgia / Hemostasia Cirúrgica / Hepatectomia / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Eletrocirurgia / Hemostasia Cirúrgica / Hepatectomia / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Itália